Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Phase 2	2026-04-27		NCT07400588

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	4

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials